Pharmacodynamics and relative bioavailability of cabergoline tablets vs solution in healthy volunteers
โ Scribed by S. Persiani; G. Sassolas; G. Piscitelli; C. A. Bizollon; I. Poggesi; E. Pianezzola; D. M. F. Edwards; M. Strolin Benedetti
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 455 KB
- Volume
- 83
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Divalproex sodium extended-release tablet (divalproex-ER), 500 mg strength, is approved for use in the prophylaxis of migraine headaches and epilepsy. The bioavailability of novel 250 mg divalproex-ER formulations, under development to allow greater flexibility in dosing, was compared with the avail
The pharmacokinetic disposition and relative bioavailability of sertindole administered as a tablet dosage form under fasting conditions, in the presence of food, in the presence of antacid, and as solution was studied in a four-way crossover in young healthy male volunteers. Overall, tablet dosing
This study was conducted to determine the relative bioavailability of Dilacorm XR capsules compared to CardizemD CD capsules at both low (180mgdPL) and high (540mgd-') dose levels. Trough and serial plasma samples were obtained and pharmacokinetic parameters were calculated from the steady state con